GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » 14-Day RSI

Kingworld Medicines Group (HKSE:01110) 14-Day RSI : 65.51 (As of May. 19, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-19), Kingworld Medicines Group's 14-Day RSI is 65.51.

The industry rank for Kingworld Medicines Group's 14-Day RSI or its related term are showing as below:

HKSE:01110's 14-Day RSI is ranked worse than
89.46% of 702 companies
in the Healthcare Providers & Services industry
Industry Median: 48.775 vs HKSE:01110: 65.51

Competitive Comparison of Kingworld Medicines Group's 14-Day RSI

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kingworld Medicines Group's 14-Day RSI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's 14-Day RSI falls into.



Kingworld Medicines Group  (HKSE:01110) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kingworld Medicines Group  (HKSE:01110) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Kingworld Medicines Group 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group (HKSE:01110) Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines